Medochemie marked its 50th anniversary in 2026, celebrating five decades of transformation from a small Limassol start-up into Cyprus’ largest pharmaceutical company and a major global exporter. Founded in 1976 by Dr. Andreas Pittas, the company has grown through a commitment to quality and innovation, now operating 15 manufacturing facilities and exporting to 120 markets worldwide.

From its beginnings in a challenging post-1974 Cyprus, Medochemie expanded internationally by adhering to strict EU GMP standards and fostering long-term partnerships. Today, it employs over 2,000 people, supports research and sustainable development, and is recognized for multiple export awards, including the prestigious European Ruban d’Honneur.

Beyond business success, Medochemie maintains strong social responsibility initiatives focusing on education, healthcare, and environmental protection. Founder Dr. Pittas credited the company’s people for its achievements and emphasized ongoing investment in emerging technologies and international growth, ensuring Medochemie’s continued role in Cypriot entrepreneurship and global pharmaceutical innovation.